Who owns DR REDDYS LABORATORIES LTD?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of RDY from SEC Form 13F filings across 238 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 238 institutions disclosed 125.6M shares of DR REDDYS LABORATORIES LTD worth $1.82B — about 15.1% of shares outstanding; the largest disclosed holder is Robeco Institutional Asset Management B.V.. Source: SEC Form 13F filings, parsed by EvidInvest.
238
13F holders
$1.82B
value, 2026 filers
15.1%
of shares outstanding (125.6M sh)
34
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of RDY's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Robeco Institutional Asset Management B.V. | 18.0M | $261.1M | 0.3% | 2.2% | +4.9% |
| 2 | MORGAN STANLEY | 10.9M | $158.5M | 0.0% | 1.3% | +16.7% |
| 3 | BlackRock, Inc. | 10.6M | $153.4M | 0.0% | 1.3% | -8.6% |
| 4 | ROYAL BANK OF CANADA | 9.2M | $133.5M | 0.0% | 1.1% | -7.7% |
| 5 | Aikya Investment Management Ltd | 8.5M | $123.1M | 36.1% | 1% | +6.2% |
| 6 | RENAISSANCE TECHNOLOGIES LLC | 7.3M | $106.5M | 0.1% | 0.9% | -6.5% |
| 7 | DIMENSIONAL FUND ADVISORS LP | 5.3M | $77.0M | 0.0% | 0.6% | -0.2% |
| 8 | STATE STREET CORP | 4.1M | $59.8M | 0.0% | 0.5% | +2.4% |
| 9 | JPMORGAN CHASE & CO | 4.1M | $60.5M | 0.0% | 0.5% | -6.9% |
| 10 | ALLIANCEBERNSTEIN L.P. | 3.7M | $51.7M | 0.0% | 0.4% | +46.8% |
| 11 | VANGUARD CAPITAL MANAGEMENT LLC | 3.1M | $44.9M | 0.0% | 0.4% | 0.0% |
| 12 | FRANKLIN RESOURCES INC | 2.8M | $41.2M | 0.0% | 0.3% | -0.4% |
| 13 | Nuveen, LLCNEW | 2.8M | $41.0M | 0.0% | 0.3% | new |
| 14 | BNP PARIBAS FINANCIAL MARKETS | 2.6M | $38.4M | 0.0% | 0.3% | -16.8% |
| 15 | ACADIAN ASSET MANAGEMENT LLC | 2.3M | $32.7M | 0.0% | 0.3% | -6.2% |
| 16 | MARSHALL WACE, LLP | 2.0M | $29.3M | 0.0% | 0.2% | -24.0% |
| 17 | BESSEMER GROUP INC | 1.9M | $26.9M | 0.0% | 0.2% | +1.9% |
| 18 | AMERICAN CENTURY COMPANIES INC | 1.8M | $26.5M | 0.0% | 0.2% | +10.2% |
| 19 | UBS Group AG | 1.7M | $24.0M | 0.0% | 0.2% | +6.8% |
| 20 | SCHRODER INVESTMENT MANAGEMENT GROUP | 1.6M | $24.0M | 0.0% | 0.2% | +793.0% |
| 21 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.5M | $22.1M | 0.0% | 0.2% | -14.2% |
| 22 | Creative Planning | 1.2M | $18.0M | 0.0% | 0.1% | +6.3% |
| 23 | LAZARD ASSET MANAGEMENT LLC | 1.2M | $17.8M | 0.0% | 0.1% | +16.2% |
| 24 | GOLDMAN SACHS GROUP INC | 1.1M | $15.3M | 0.0% | 0.1% | +74.8% |
| 25 | NORTHERN TRUST CORP | 1.0M | $15.0M | 0.0% | 0.1% | -5.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.